EMA Should Lead AI Oversight In Pharma & Align With Global Regulators, Says EFPIA

The European Medicines Agency should be responsible for the regulatory oversight of AI in the drug development process in the EU and provide clarity on its “risk-based” approach to governance, pharma industry federation EFPIA says.